mqc_gatk-base-recalibrator-quality-scores-plot_Pre-recalibration_Percent.svg

syn62402607

Created By Orca Service orca-service

studyId: syn53604892
studyName: Advancing RAS pathway targeted therapy in NF1-MPNST - effects of SHP2 and CDK4 or CDK6 inhibitors on the tumor and the tumor immune microenvironment
initiative: Other
fundingAgency: Other

mqc_gatk-base-recalibrator-quality-scores-plot_Pre-recalibration_Percent.svg page is loading…